BRIUMVI 150 MG CONCENTRADO PARA SOLUCION PARA PERFUSION

Neuraxpharm Pharmaceuticals S.L.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: b6df5954238de3a8
Drug Cima Aemps Name: BRIUMVI 150 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1231730001
Holder Company Name: Neuraxpharm Pharmaceuticals S.L.
Marketing Company Name: Neuraxpharm Spain S.L.
Holder Company Detail Path: /organization/neuraxpharm-pharmaceuticals-s-l
Authorization Date: 2023-11-14
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 150 MG
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Neuraxpharm Pharmaceuticals S.L.
Company Detail Path: /organization/neuraxpharm-pharmaceuticals-s-l

UBLITUXIMAB

150 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 14, 2023

Approval ID

b6df5954238de3a8

Type

Standard